Weight gain, gender, and antipsychotics: a disproportionality analysis of the FDA Adverse Event Reporting System database (FAERS)-Reference-Cited by-同舟云学术

Weight gain, gender, and antipsychotics: a disproportionality analysis of the FDA Adverse Event Reporting System database (FAERS)

Published:2023-08-21 Issue: Volume: Page:1-7
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Stamoula Eleni¹²,Stamatellos Vasileios-Periklis³,Vavilis Theofanis⁴⁵,Dardalas Ioannis¹,Papazisis Georgios¹⁶

Affiliation:

1. Department of Clinical Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece

2. Department of Biotechnology, Centre of Systems Biology, Biomedical Research Foundation of the Academy of Athens, Athens, Greece

3. Department of Neurology, Klinik fur Neurologie, DRK Kliniken, Berlin Kopenick, Berlin, Germany

4. Department of Dentistry, School of Medicine, European University of Cyprus, Nicosia, Cyprus

5. Laboratory of Medical Biology and Genetics, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece

6. Clinical Trials Unit, Special Unit for Biomedical Research and Education, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2023.2248873

Reference49 articles.

1. Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents

2. Immunoendocrine Peripheral Effects Induced by Atypical Antipsychotics

3. Atypical Antipsychotics: Mechanism of Action

4. Psychopharmacological treatment of schizophrenia: What do we have, and what could we get?

5. A Survey of Drug-Induced Extrapyramidal Reactions